| III-057 Zinnia Parra-Guillen Optimal study design for pharmacokinetic modeling of teicoplanin in critically ill children, including those undergoing Continuous Renal Replacement Therapy Thursday 09:50-11:20 |
| III-057 Zinnia Parra-Guillen Optimal study design for pharmacokinetic modeling of teicoplanin in critically ill children, including those undergoing Continuous Renal Replacement Therapy Thursday 09:50-11:20 |